Vaccine Improves Brain Cancer Survival

Tuesday, 17 Sep 2013 02:56 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Biotechnology company Agenus Inc. said its experimental brain cancer vaccine increased the survival of patients without their cancer worsening in a mid-stage trial, compared with the standard treatment.

The vaccine, codenamed HSPPC-96, showed an almost 18 month median progression-free survival — a 160 percent increase versus current standard treatment of radiation combined with chemotherapy drug temozolomide.
 
The vaccine was being used in combination with the standard treatment to treat patients with newly diagnosed glioblastoma multiforme, an aggressive type of tumor which affects the brain.
 
Agenus plans to discuss a late-stage trial with the U.S. Food and Drug Administration, based on the trial data.
 
A preliminary analysis of the study in May had showed that the vaccine had a 146 percent increase in progression-free survival when compared with the standard-of-care.
 
"We are impressed by the data and look forward to feedback from the FDA regarding next steps," Roth Capital Partners analyst Joseph Pantginis wrote in a note.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Two Ebola Patients Coming to US

Friday, 01 Aug 2014 17:12 PM

Two American aid workers, both seriously ill after being infected with the deadly Ebola virus in Liberia, will be flown  . . .

New Type 2 Diabetes Drug Gets FDA OK

Friday, 01 Aug 2014 16:11 PM

The U.S. Food and Drug Administration announced on Friday that itapproved a new drug, Jardiance, to help fight Type 2 di . . .

Why Isn't There a Vaccine or Treatment for Ebola?

Friday, 01 Aug 2014 16:01 PM

In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no li . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved